Skip to contentKutzkey Tim — Surrozen, Inc./DE insider: 73 transactions · InsiderLensKutzkey Tim
- 10% owner at Tenaya Therapeutics, Inc. · on record since Feb 26, 2026
- 10% owner at Eikon Therapeutics, Inc. · on record since Feb 9, 2026
- Director at Surrozen, Inc./DE · on record since May 19, 2026
- 10% owner at Surrozen, Inc./DE · on record since May 19, 2026
- 10% owner at Nurix Therapeutics, Inc. · on record since May 7, 2021
- 10% owner at Immune Design Corp. · on record since Oct 30, 2017
- 10% owner at Arcus Biosciences, Inc. · on record since Mar 19, 2018
- 10% owner at CONSTAR INTERNATIONAL INC · on record since Jul 23, 2018
- 10% owner at NGM BIOPHARMACEUTICALS INC · on record since Jun 14, 2019
- 10% owner at Giddy-up Productions, Inc. · on record since Sep 29, 2021
- 10% owner at Revolution Medicines, Inc. · on record since Nov 18, 2020
- General Partner at NGM BIOPHARMACEUTICALS INC · on record since Jan 25, 2023
Insider trading activity of Kutzkey Tim
- Transactions on record
- 73
- since Jun 21, 2019
- Open-market buys
- 45
- $19.2M
- Open-market sells
- 1
- $12.3M
- Companies traded
- 3
- last filing May 19, 2026
Figures computed from official regulatory filings — methodology.
Companies where Kutzkey Tim has traded
Track record of Kutzkey Tim
Statistical track record
Free- Open-market buys
- 53
- Last buy
- Jan 20, 2026
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Kutzkey Tim
Co-insiders of Kutzkey Tim
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
COLUMN GROUP II, LPArcus Biosciences, Inc. +4
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| May 19, 2026 | AwardD | 5,550 | 0.00 USD | $0 | SEC |
| Jan 20, 2026 | Buy | 9,568 | 19.60 USD | $187.5K | SEC |
| Jan 20, 2026 | Buy | 1,204 | 20.00 USD | $24.1K | SEC |
| Jan 20, 2026 | Buy | 8,484 | 19.60 USD | $166.3K | SEC |
| Jan 20, 2026 | Buy | 5,590 | 19.89 USD | $111.2K | SEC |
| Jan 20, 2026 | Buy | 1,358 | 20.00 USD | $27.2K | SEC |
| Jan 20, 2026 | Buy | 6,303 | 19.89 USD | $125.4K | SEC |
| Jan 15, 2026 | Buy | 6,609 | 19.80 USD | $130.9K | SEC |
| Jan 15, 2026 | Buy | 2,596 | 19.99 USD | $51.9K | SEC |
| Jan 15, 2026 | Buy | 2,927 | 19.99 USD | $58.5K | SEC |
| Jan 15, 2026 | Buy | 5,861 | 19.80 USD | $116K | SEC |
| Jan 8, 2026 | Buy | 8,003 | 19.89 USD | $159.2K | SEC |
| Jan 8, 2026 | Buy | 7,097 | 19.89 USD | $141.2K | SEC |
| Dec 8, 2025 | Buy | 2,791 | 17.35 USD | $48.4K | SEC |
| Dec 8, 2025 | Buy | 16,381 | 19.54 USD | $320.1K | SEC |
| Dec 8, 2025 | Buy | 2,475 | 17.35 USD | $42.9K | SEC |
| Dec 8, 2025 | Buy | 14,503 | 19.54 USD | $283.4K | SEC |
| Dec 2, 2025 | Buy | 167,307 | 12.65 USD | $2.1M | SEC |
| Dec 2, 2025 | Buy | 148,150 | 12.65 USD | $1.9M | SEC |
| Mar 28, 2025 | AwardD | 2,666 | 0.00 USD | $0 | SEC |
| Jun 6, 2024 | AwardD | 1,333 | 0.00 USD | $0 | SEC |
| Apr 17, 2024 | Buy | 102,651 | 15.50 USD | $1.6M | SEC |
| Apr 17, 2024 | Buy | 90,897 | 15.50 USD | $1.4M | SEC |
| Apr 8, 2024 | Buy | 90,897 | 15.50 USD | $1.4M | SEC |
| Apr 8, 2024 | Other | -968,990 | — | — | SEC |